United States: First Nonprescription Birth Control Pill Approved For Marketing By FDA: A Milestone For Reproductive Health - Mintz
Perrigo/HRA Pharma has stated that the product, called OPill®, will be launched commercially during the first quarter of 2024.
Full Article